Global Degenerative Disc Disease Treatment Market Analysis: Size, Drivers, Trends, Opportunities And Strategies
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033
The degenerative disc disease treatment market size has experienced significant growth in recent years, projected to increase from $25.33 billion in 2023 to $27.07 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. This historic growth can be attributed to various factors, including an aging population, sedentary lifestyles, advancements in medical technology, increased awareness of spine health, rising obesity rates, and a growing incidence of sports injuries, alongside expanded access to healthcare. Looking ahead, the market is expected to continue its strong growth trajectory, reaching $35.45 billion by 2028 at a CAGR of 7.0%. Contributing to this forecasted growth are factors such as rising healthcare expenditures, increasing demand for minimally invasive procedures, enhanced patient education, expanding clinical research, and the rising global incidence of spine disorders. Key trends anticipated in the forecast period include the integration of AI and machine learning, developments in regenerative medicine, advancements in minimally invasive surgery, wearable technology, 3D printing for custom implants, the expansion of telemedicine and remote consultations, and a heightened focus on personalized medicine.
The increasing incidence of sports injuries is expected to fuel the growth of the degenerative disc disease treatment market in the foreseeable future. Sports injuries refer to physical damage or trauma sustained by athletes or individuals involved in physical activities, often resulting from sudden impacts, overuse, or improper techniques. The rise in sports injuries can be attributed to several factors, including higher participation rates, more intense training regimens, and a greater focus on competitive performance. Degenerative disc disease treatment is employed to manage chronic spinal pain and restore functionality when disc degeneration affects athletes’ performance and mobility. For example, in June 2022, the National Safety Council, a US-based nonprofit public service organization, indicated that 3.2 million people were treated in emergency departments for injuries involving sports and recreational equipment. The number of injuries increased by 20% in 2021, rising to 409,224 injuries from 377,939 in 2020. Therefore, the rising incidence of sports injuries is a significant driver of growth in the degenerative disc disease treatment market.
Get A Free Sample On The Degenerative Disc Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18784&type=smp
What Are The Key Trends That Influence Degenerative Disc Disease Treatment Market Share Analysis?
Major companies in the degenerative disc disease treatment market are concentrating on developing novel therapies such as injectable disc cell therapy (IDCT) to improve patient outcomes by increasing disc volume, alleviating low back pain, and decreasing dependence on pain medications. Injectable disc cell therapy (IDCT) is a regenerative treatment targeting symptomatic lumbar degenerative disc disease. For example, in February 2023, DiscGenics Inc., a US-based biopharmaceutical company, received FDA regenerative medicine advanced therapy designation for its IDCT, which aims to treat symptomatic lumbar degenerative disc disease. This innovative therapy utilizes a live progenitor cell population derived from donated adult human intervertebral disc tissue. IDCT has the potential to enhance disc volume, alleviate low back pain, and reduce the need for pain medication in affected patients.
Which Market Players Are Driving Growth In The Degenerative Disc Disease Treatment Market?
Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health
How Is The Global Degenerative Disc Disease Treatment Market Segmented?
The degenerative disc disease treatment market covered in this report is segmented –
1) By Type: Conventional Drugs, Novel Therapies
2) By Route Of Administration: Oral, Injectable
3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Center
Read The Full Degenerative Disc Disease Treatment Market Report Here
The Degenerative Disc Disease Treatment Global Market Report 2024 provides an overview of the degenerative disc disease treatmentmarket for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The degenerative disc disease treatment market forecast analyzes degenerative disc disease treatment market size, degenerative disc disease treatment market share, leading competitor and their market positions.
The Table Of Content For The Degenerative Disc Disease Treatment Market Include
1. Degenerative Disc Disease Treatment Market Executive Summary
2. Degenerative Disc Disease Treatment Market Segments
3. Degenerative Disc Disease Treatment Market Size And Template Market Growth Rate
4. Key Degenerative Disc Disease Treatment Market Trends
5. Major Degenerative Disc Disease Treatment Market Drivers
……
25. Key Mergers And Acquisitions In The Degenerative Disc Disease Treatment Market
26. Top Degenerative Disc Disease Treatment Companies
27. Degenerative Disc Disease Treatment Market Opportunities And Strategies
28. Degenerative Disc Disease Treatment Market, Conclusions And Recommendations
29. Appendix
Explore Similar Reports From The Business Research Company:
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Inflammatory Bowel Disease Treatment Global Market Report 2024
Chronic Disease Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
